En mulig forklaring på den øgede risiko for myopati i forbindelse med fluvastatin er større brug af erythromycin og azol antifungale midler i denne gruppe.
A possible explanation of the increased risk of myopathy with fluvastatin was there was a higher use of erythromycin and azole antifungals in this group.